Chinese consensus on the prevention and treatment of glucocorticoid induced osteoporosis (2020)

Glucocorticoid induced osteoporosis (GIOP) is the most common secondary osteoporosis. The prevention and treatment of the disease need urgent attention. In 2013, the Chinese Rheumatology Association of Chinese Medical Association proposed the Chinese consensus on the diagnosis and treatment of GIOP. Recently, great progress was harvested in epidemiology, fracture risk assessment and pharmaceutical therapy of GIOP. Because of the wide usage of glucocorticoids, a multidisciplinary team has updated the consensus of GIOP under the leadership of several scientific and academic committees. Applying the grading of recommendations assessment, development and evaluation (GRADE) approach, this consensus provides detailed recommendations for several important issues such as stratified assessment of fractures, treatments under different stratification, conversion, maintenance and withdraw, and management of special patients. This consensus is intended to serve as a tool for Chinese clinicians to standardize prevention and treatment of the disease and to improve medical care for these patients.